Nodenza Venture Partners
Emerging managerBuilt from this firm's Form D filings. The firm files no SEC adviser report.
- Website
- https://nodenza.com
- HQ
- NY
Nodenza Venture Partners focuses on finding and investing in disruptive technologies and therapies that could deliver exceptional benefits to patients.
01 · Says / Does
| Tag | Says | Does |
|---|---|---|
| Stages | Not stated | Not enough dated deals |
| Sectors | Biotech, Medical devices | Not enough dated deals |
| Regions | Not stated | Not enough dated deals |
Says: what the firm's funds state. Does: from 0 dated deals in the last 24 months.
02 · Fund history
| Fund | Year | Size | Status |
|---|---|---|---|
| Nodenza Venture Partners I, L.P. Nodenza seeks and invests in disruptive life sciences technologies and therapies with the potential to deliver exceptional benefits to patients. It invests at the clinical and product launch value inflection points of the life sciences value chain. Inferred from the firm's website | 2024 | $5.3M (Form D) | Open, writing first checks |
03 · People across funds
- Ross Morton
Nodenza Venture Partners I, L.P. (Named on Form D)
04 · Recent deals
No dated deals found yet.
05 · Latest from the firm
No news from the firm's website yet.
06 · Sources
Fund dates and sizes are from SEC Form D filings.
Last verified: Oct 28, 2026